New combo therapy aims to beat tough childhood cancer
Disease control
Recruiting now
This study is for children aged 0-18 with a severe form of Langerhans cell histiocytosis (LCH) that affects multiple organs. It compares standard chemotherapy alone to the same chemotherapy plus a targeted drug called luvometinib. The goal is to see if adding luvometinib helps mo…
Phase: NA • Sponsor: West China Second University Hospital • Aim: Disease control
Last updated May 20, 2026 11:57 UTC